Creative Medical Technology Holdings, Inc.
CELZNasdaqCIK 1187953HealthcareFiscal year ends Dec 31
Reports and events: 218 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-05-1216:30 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001477932-23-003347 |
| 2023-05-0116:45 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001477932-23-003013 |
| 2023-03-3116:46 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001477932-23-002123 |
| 2022-12-1916:01 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-22-009401 |
| 2022-11-1016:45 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001477932-22-008323 |
| 2022-10-2616:05 ET | DEF 14A | Proxy statementPeriod 2022-10-25 | 0001477932-22-007942 |
| 2022-08-1216:46 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001477932-22-005931 |
| 2022-07-1416:01 ET | 8-K | 3.01 Delisting notice | 0001477932-22-005098 |
| 2022-05-1316:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001477932-22-003286 |
| 2022-05-0416:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-22-002951 |
| 2022-05-0416:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-22-002950 |
| 2022-04-2916:06 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001477932-22-002753 |
| 2022-04-2216:54 ET | S-1 | Registration statement | 0001477932-22-002561 |
| 2022-03-3016:30 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001477932-22-001741 |
| 2022-02-1117:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-22-000691 |
| 2021-12-0716:05 ET | 8-K | 1.01 Entry into a material agreement; 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-21-009015 |
| 2021-12-0210:49 ET | S-1/A | Registration statement, amended | 0001477932-21-008899 |
| 2021-12-0109:04 ET | S-1/A | Registration statement, amended | 0001477932-21-008880 |
| 2021-11-2316:06 ET | S-1/A | Registration statement, amended | 0001477932-21-008759 |
| 2021-11-1516:45 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001477932-21-008404 |
| 2021-11-0916:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-007944 |
| 2021-11-0516:35 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-21-007874 |
| 2021-09-2818:22 ET | S-1 | Registration statement | 0001477932-21-006729 |
| 2021-09-2216:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001477932-21-006554 |
| 2021-08-1616:46 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001477932-21-005614 |
| 2021-08-1216:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-21-005384 |
| 2021-05-1716:45 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001477932-21-003351 |
| 2021-04-0216:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-21-002013 |
| 2021-03-2509:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-001641 |
| 2021-03-1717:26 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001477932-21-001495 |
| 2021-03-1216:05 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-001400 |
| 2021-03-0516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-001246 |
| 2021-02-2216:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-001008 |
| 2021-02-2209:15 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-21-000992 |
| 2021-02-1816:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001477932-21-000950 |
| 2021-02-1210:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-000799 |
| 2021-02-0816:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-000686 |
| 2021-01-1408:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-000247 |
| 2021-01-0416:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-21-000025 |
| 2020-11-1316:45 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001477932-20-006527 |
| 2020-08-1416:31 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001477932-20-004986 |
| 2020-05-1516:31 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001104659-20-062662 |
| 2020-04-0616:02 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001104659-20-043660 |
| 2020-03-2416:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-20-037744 |
| 2020-01-3116:02 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-20-009235 |
| 2019-11-1416:46 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001104659-19-064296 |
| 2019-10-1616:02 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001104659-19-054379 |
| 2019-09-0916:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001144204-19-043926 |
| 2019-08-1316:48 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001144204-19-039574 |
| 2019-07-3112:26 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001144204-19-036809 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 19:08 ET. Listed shows no prices and gives no investment advice.